27 Oct 2015

Ganfort (Bimatoprost / Timolol) - Italia

ATC: S01ED
SENSORY ORGANS
OPHTHALMOLOGICALS
ANTIGLAUCOMA PREPARATIONS AND MIOTICS
BETA BLOCKING AGENTS
Ganfort

Last Updated on 27 Oct 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Ganfort Indication

Riduzione della pressione intraoculare (PIO) in pazienti adulti con glaucoma ad angolo aperto o con ipertensione oculare, che non rispondono adeguatamente ai beta-bloccanti o agli analoghi delle prostaglandine per uso topico.

 

Ganfort Generic Name

Bimatoprost / Timolol

Type

POM

Summary Product Characteristics (SPCs) Links
Riassunto delle Caratteristiche del Prodotto - Ganfort (external site)

Related Learning Zones

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Oral Anticoagulation Reversal Knowledge Centre

Oral Anticoagulation Reversal Knowledge Centre

The Oral Anticoagualtion Reversal Knowledge Centre is intended to provide healthcare professionals with accurate information on the approaches to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding, or require surgery. Content is arranged within illustrated and referenced sections including management of bleeding risk, oral anticoagulants, symposium highlights, key publication summaries and more.

This resource is developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with content provided by CSL Behring.

This resource is not intended for healthcare professionals outside Europe.

Selected content related to Ganfort (Bimatoprost / Timolol)

Guidelines

Ganfort Marketing Information

Ganfort Generic Name
Bimatoprost / Timolol
Marketing Company
Allergan Pharmaceuticals Ireland
Drug Type
POM
Date of Issue, Marketing Authority

19/05/2006

Related Drugs - Eye Health and Disorders

Back to top